VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Neha Pagidipati, MD
Duke Clinical Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Univ. of Alabama - Birmingham
Birmingham, Alabama, United States
- Univ. of California - Irvine
Orange, California, United States
- San Francisco General Hospital
San Francisco, California, United States
- Emory University
Atlanta, Georgia, United States
- Wellstar Paulding
Hiram, Georgia, United States
- Rush University
Chicago, Illinois, United States
- University of Iowa
Iowa City, Iowa, United States
- Jhu - Suburban Hospital
Bethesda, Maryland, United States
- Johns Hopkins
Columbia, Maryland, United States
- Essentia Health
Duluth, Minnesota, United States
- University of Missouri
Columbia, Missouri, United States
- Washington University
St Louis, Missouri, United States
- University of Nebraska
Omaha, Nebraska, United States
- Heart House of Nj
Haddon Heights, New Jersey, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Temple University
Philadelphia, Pennsylvania, United States
- Medical Univ. of South Carolina
Charleston, South Carolina, United States
- Houston Methodist
Houston, Texas, United States
- Baylor Scott & White - Waco
Waco, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Dec 2024
- Primary completion
- 31 Dec 2026
- Completion
- 28 Feb 2027
- Last update posted
- 6 Nov 2025
- Registered enrollment
- 130
- Registry id
- NCT06249165
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.